Aryanna LeBron

In episode 3 of Amplifying Technicians, host Taylor Watterson, PharmD, PhD, assistant professor at the University of Illinois Chicago Retzky College of Pharmacy, welcomes Grace Fick, PharmD candidate and pharmacy research assistant at Retzky. The duo has collaborated on multiple research projects in the past and they are now gathering to discuss their experiences with being technicians during pharmacy school.

With pharmacies gradually gaining more and more clinical services to provide and bill for, they are often running into issues regarding credentialing as well as finding the properly regulated services to bill for in the first place. “[The] big thing is credentialing,” Jennifer Griffin, PharmD, MS, clinical pharmacist at Harps Food Stores, Inc, told Drug Topics.

In March 2024, the FDA approved aprocitentan (Tryvio), an endothelin receptor antagonist, for the treatment of hypertension in combination with other antihypertensive medications. The approval is specifically for lowering blood pressure in adult patients in which it is not adequately controlled by other medications. Efficacy The approval of Tryvio was based on the multipart, phase 3 multicenter PRECISION study (NCT03541174), which was conducted by Idorsia Pharmaceuticals.